電子書籍詳細

電子書籍詳細


洋書 kinoppy

高血圧:ブラウンワルド・コンパニオン(第3版)

Hypertension: A Companion to Braunwald's Heart Disease E-Book

3

(Companion to Braunwald's Heart Disease)

Bakris, George L.   Sorrentino, Matthew

Elsevier 2017/01
544p.
出版国: US
ISBN: 9780323429733
eISBN: 9780323508766
KNPID: EY00116410
販売価格 : BookWeb Pro特別価格

価格はログインすると表示されます。
為替レートの変動や出版社の都合によって、価格が変動する場合がございます。
ファイルフォーマット:   
ファイルサイズ:
デバイス:

ご購入を希望される方は、
下のリンクをクリックしてください。

Full Description

The third edition of Hypertension: A Companion to Braunwald's Heart Disease, by Drs. George L. Bakris and Matthew Sorrentino, focuses on every aspect of managing and treating patients who suffer from hypertensive disorders. Designed for cardiologists, endocrinologists and nephrologists alike, this expansive, in-depth review boasts expert guidance from contributors worldwide, keeping you abreast of the latest developments from basic science to clinical trials and guidelines.

  • Features expert guidance from worldwide contributors in cardiology, endocrinology, neurology and nephrology.
  • Covers behavior management as an integral part of treatment plans for hypertensives and pre-hypertensives.
  • Covers new developments in epidemiology, pathophysiology, immunology, clinical findings, laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, prognosis, and management.
  • Includes chapters on hot topics such as hypertension as an immune disease; sleep disorders including sleep apnea, a major cause of hypertension; a novel chapter on environmental pollution and its contribution to endothelial dysfunction, and more!
  • Equips you with the most recent guidelines from the major societies.
  • Updates sourced from the main Braunwald's Heart Disease text.
  • Highlights new combination drug therapies and the management of chronic complications of hypertension.

Table of Contents

SECTION I: EPIDEMIOLOGY

1. General Population and Global Cardiovascular Risk Prediction

2. Hypertension in Latin/Hispanic Population

3. Hypertension in East Asians and Native Hawaiians

4. Hypertension in South Asians

SECTION II: PATHOPHYSIOLOGY

5. Pathogenesis of Hypertension

6. Genetics of Hypertension

7. Inflammation and Immunity in Hypertension

SECTION III: DIAGNOSIS AND EVALUATION

8. The Environment and High Blood Pressure

9. Office Blood Pressure Measurement

10. Home Monitoring of Blood Pressure

11. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management

12. White Coat and Masked Hypertension

13. Renovascular Hypertension and Ischemic Nephropathy

14. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States

15. Secondary Hypertension: Pheochromocytoma and Paraganglioma

16. Secondary Hypertension: Sleep Disturbances including Sleep Apnea

17. Hypertension in Children: Diagnosis and Treatment

SECTION IV: RISK STRATIFICATION

18. Natural History of Untreated Hypertension

19. Isolated Systolic Hypertension

20. Assessment of Target Organ Damage

SECTION V: ANTIHYPERTENSIVE THERAPY

21. Diet and Blood Pressure

22. Diuretics in Hypertension

23. Alpha Blockers and Hypertension

24. Renin Angiotensin Aldosterone System Blockers

25. Calcium Channel Blockers

26. Central Sympathetic Agents and Direct Vasodilators

27. Use of Combination Therapies

28. Devices Therapies

29. Alternative Approaches for Lowering Blood Pressure

SECTION VI: HYPERTENSION MANAGEMENT

30. Approach to Difficult to Manage Primary Hypertension

31. Hypertension in Ischemic Heart Disease

32. Heart Failure

33. Hypertension and Chronic Kidney Disease

34. Transplant Hypertension

35. Obesity

36. Cerebrovascular Disease

37. Diabetes Mellitus

38. Dyslipidemia

SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS

39. Hypertension in Pregnancy

40. Hypertension in Older People

41. Hypertension in African Americans

42. Baroreceptor Dysfunction/Orthostatic Hypotension

43. Resistant Hypertension

44. Hypertension and the Perioperative Period

45. Aorta and Peripheral Arterial Disease in Hypertension

46. Hypertensive Emergencies and Urgencies

SECTION VIII: OUTCOME TRIALS

47. Meta-Analyses of Blood Pressure Lowering Trials and the Blood Pressure Lowering Treatment Trialists’ Collaboration

SECTION IX: HYPERTENSION TREATMENT IN THE FUTURE

48. Team-Based Care for Hypertension Management

49. Understanding and Improving Medication Adherence

SECTION X: GUIDELINES

50. Updated AHA/ACC; ESH/ISH

51. Putting All Guidelines into Perspective